Camryn Lieb, ScM

Genesis Research Group
Hoboken, New Jersey, United States

Presentation(s):

• Paper 37 - IMPACT OF PRIOR SYSTEMIC THERAPY ON TAZEMETOSTAT EFFICACY IN ADVANCED EPITHELIOID SARCOMA: POST HOC ANALYSIS OF STUDY EZH-202

  Friday, November 14, 2025
  10:30 AM - 12:00 PM EST

  Disclosure information not submitted.